The Wisconsin Alzheimer’s Disease Research Center supports researchers in their pursuit of answers that will lead to improved diagnosis and care for patients while, at the same time, focusing on the program’s long-term goal — finding a way to prevent and effectively treat Alzheimer’s disease.

Learn more

Recent News

screengrab of dr. cynthia carlsson in an interview
Cynthia Carlsson, MD, MS, is leading a research team at UW–Madison investigating a drug that could one day prevent Alzheimer’s disease.
Headshot of Andrea Gilmore-Bykovskyi
The annual awards acknowledge and honor women of color among UW–Madison’s faculty, staff, students and in the greater Madison community whose advocacy, activism, or scholarship has fostered social justice and organizational change.
Graphic with Dr. Kimberly Mueller's headshot announcing her appointment to associate professor
Kimberly Mueller, PhD, CCC-SLP, was recently appointed to associate professor with tenure in the Department of Communication Sciences and Disorders at the University of Wisconsin–Madison.
Stock photo of a man in military clothes holding a young dog
Brain assessments of World War II, Korean and Vietnam War-era veterans uncover disease biomarkers.
Nathaniel Chin, MD, at his desk with the Journal of the American Geriatrics Society logo on his computer
Nathaniel Chin, MD, discusses the impact of new Alzheimer’s treatments in memory care in a commentary published in the Journal of the American Geriatrics Society.
Words "CLINICAL TRIAL" with hand holding a magic marker. Includes the LUCINDA logo and Wisconsin ADRC logo.
Researchers are investigating whether the drug leuprolide, which is approved for prostate cancer in men, can be used to treat symptoms of Alzheimer’s disease in women.